29.86
price down icon2.74%   -0.84
after-market After Hours: 29.86
loading
Collegium Pharmaceutical Inc stock is traded at $29.86, with a volume of 237.64K. It is down -2.74% in the last 24 hours and up +0.98% over the past month. Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
See More
Previous Close:
$30.70
Open:
$30.32
24h Volume:
237.64K
Relative Volume:
0.83
Market Cap:
$959.46M
Revenue:
$566.77M
Net Income/Loss:
$48.16M
P/E Ratio:
25.09
EPS:
1.19
Net Cash Flow:
$274.29M
1W Performance:
-7.01%
1M Performance:
+0.98%
6M Performance:
-7.04%
1Y Performance:
-22.58%
1-Day Range:
Value
$29.73
$30.68
1-Week Range:
Value
$29.73
$32.38
52-Week Range:
Value
$23.23
$42.29

Collegium Pharmaceutical Inc Stock (COLL) Company Profile

Name
Name
Collegium Pharmaceutical Inc
Name
Phone
781-713-3699
Name
Address
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Name
Employee
357
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
COLL's Discussions on Twitter

Compare COLL with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
COLL
Collegium Pharmaceutical Inc
29.86 986.77M 566.77M 48.16M 274.29M 1.19
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
145.79 66.25B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.72 42.95B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.43 43.30B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
15.45 19.30B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
NBIX
Neurocrine Biosciences Inc
128.23 13.53B 2.41B 305.80M 492.20M 2.95

Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-10-25 Upgrade Needham Hold → Buy
Jul-30-24 Upgrade H.C. Wainwright Neutral → Buy
Jun-07-24 Upgrade Jefferies Hold → Buy
May-10-24 Downgrade Needham Buy → Hold
May-10-24 Downgrade Piper Sandler Overweight → Neutral
Jan-04-24 Downgrade Jefferies Buy → Hold
Aug-25-23 Reiterated Needham Buy
May-02-23 Resumed Jefferies Buy
Aug-08-22 Downgrade H.C. Wainwright Buy → Neutral
Feb-15-22 Upgrade Cantor Fitzgerald Neutral → Overweight
Aug-06-21 Downgrade Cantor Fitzgerald Overweight → Neutral
Jan-11-21 Reiterated H.C. Wainwright Buy
Jul-14-20 Initiated BWS Financial Sell
May-27-20 Initiated Guggenheim Neutral
Feb-19-20 Resumed Jefferies Buy
Oct-30-19 Reiterated Needham Buy
May-03-19 Resumed H.C. Wainwright Buy
Apr-12-19 Resumed Janney Buy
Mar-20-19 Initiated SunTrust Hold
Jan-16-19 Reiterated Needham Buy
Mar-08-18 Reiterated H.C. Wainwright Buy
Feb-07-18 Reiterated Needham Buy
Dec-05-17 Reiterated Needham Buy
Sep-11-17 Initiated H.C. Wainwright Buy
May-11-17 Reiterated Needham Buy
Sep-13-16 Initiated Gabelli & Co Buy
Jun-01-15 Initiated Jefferies Buy
Jun-01-15 Initiated Needham Buy
Jun-01-15 Initiated Piper Jaffray Overweight
View All

Collegium Pharmaceutical Inc Stock (COLL) Latest News

pulisher
Jul 31, 2025

Collegium Pharmaceutical (COLL) Q2 Earnings Preview: What's in the Cards? - Yahoo Finance

Jul 31, 2025
pulisher
Jul 31, 2025

Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) P/E Still Appears To Be Reasonable - simplywall.st

Jul 31, 2025
pulisher
Jul 30, 2025

Institutional Tools Highlight Unusual Flow in Collegium Pharmaceutical Inc.Trade Ready Stock Watch for Short Term Published - metal.it

Jul 30, 2025
pulisher
Jul 30, 2025

Real time social sentiment graph for Collegium Pharmaceutical Inc.Stock Market Watch with Smart Filters - Newser

Jul 30, 2025
pulisher
Jul 29, 2025

Published on: 2025-07-29 16:28:51 - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Collegium Pharmaceutical - WBFF

Jul 29, 2025
pulisher
Jul 29, 2025

Identifying reversal signals in Collegium Pharmaceutical Inc.Predictive AI Engine for Smart Investing - Newser

Jul 29, 2025
pulisher
Jul 28, 2025

Is Collegium Pharmaceutical Inc. stock overvalued or undervaluedStock Strategy Tracker With High Returns - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What are the latest earnings results for Collegium Pharmaceutical Inc.Expert Picks Signals To Watch Now - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Multi asset correlation models including Collegium Pharmaceutical Inc.Stock Entry Points Based on Technicals - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Can Collegium Pharmaceutical Inc. recover in the next quarterPredictive Model for Intraday Swing Forecast - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

What data driven models say about Collegium Pharmaceutical Inc.’s futureAlpha Trade Flow With Risk Calibration - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

3 Reasons to Avoid COLL and 1 Stock to Buy Instead - Yahoo Finance

Jul 28, 2025
pulisher
Jul 28, 2025

How many analysts rate Collegium Pharmaceutical Inc. as a “Buy”Turbocharged investment results - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Why is Collegium Pharmaceutical Inc. stock attracting strong analyst attentionGet timely market insights for better trades - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Should I hold or sell Collegium Pharmaceutical Inc. stock in 2025Invest confidently with data-driven strategies - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

What makes Collegium Pharmaceutical Inc. stock price move sharplyTremendous financial leverage - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Published on: 2025-07-28 05:52:28 - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Does Collegium Pharmaceutical Inc. stock perform well during market downturnsAchieve remarkable returns with smart investing - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How Resilient Is Collegium Pharmaceutical Inc. Stock During Economic DownturnsFree Professional Portfolio Management - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

What risks could impact Collegium Pharmaceutical Inc. stock performanceFree Insider Trading Tips - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

How Collegium Pharmaceutical Inc. stock performs during market volatilityFree Stock Selection - Newser

Jul 27, 2025
pulisher
Jul 25, 2025

How high can Collegium Pharmaceutical Inc. stock price go in 2025Breakneck growth rates - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

Is Collegium Pharmaceutical Inc. a good long term investmentOutstanding capital appreciation - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Wall Street Analysts See a 33.91% Upside in Collegium Pharmaceutical (COLL): Can the Stock Really Move This High? - Yahoo Finance

Jul 25, 2025
pulisher
Jul 25, 2025

Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now? - Yahoo Finance

Jul 25, 2025
pulisher
Jul 24, 2025

What drives Collegium Pharmaceutical Inc. stock priceMarket-leading profit generation - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

Will Collegium Pharmaceutical Inc. stock benefit from AI tech trendsOutstanding growth strategies - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

Will Collegium Pharmaceutical Inc. stock split in the near futureFree Predictions - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025 - GlobeNewswire

Jul 24, 2025
pulisher
Jul 24, 2025

Collegium Pharmaceutical, Inc. Announces Q2 2025 Financial Results Release and Conference Call Details - Nasdaq

Jul 24, 2025
pulisher
Jul 24, 2025

Press Release: Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025 - 富途牛牛

Jul 24, 2025
pulisher
Jul 24, 2025

Victory Capital Management Inc. Sells 60,823 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World

Jul 24, 2025
pulisher
Jul 23, 2025

Bank of New York Mellon Corp Sells 10,426 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World

Jul 23, 2025
pulisher
Jul 23, 2025

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Bank of New York Mellon Corp - Defense World

Jul 23, 2025
pulisher
Jul 22, 2025

Collegium Pharmaceutical Inc. Stock Analysis and ForecastSkyrocketing investment returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Collegium Pharmaceutical Inc. stockLightning-fast capital gains - jammulinksnews.com

Jul 22, 2025

Collegium Pharmaceutical Inc Stock (COLL) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$71.19
price down icon 0.90%
$13.68
price down icon 3.12%
$8.74
price down icon 2.89%
drug_manufacturers_specialty_generic RDY
$14.22
price up icon 0.85%
$274.70
price down icon 2.57%
$128.23
price down icon 6.24%
Cap:     |  Volume (24h):